RxDoctor Payments Data

Kara Krejci Reed, DPM

Foot & Ankle Surgery · Lincoln, NENPI 1912211657

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 54.2% of the total. Reporting peaked in 2019 at $4,001 and has fallen 95.4% since, to $186 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.

$6,406in general payments, 2019–2025

Across 58 payments — averaging $110.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Conetic Solutions, Inc.$894
  • Musculoskeletal Transplant Foundation Inc.$700
  • Integra Lifesciences Corporation$532
  • Organogenesis Inc.$217
  • Zimmer Biomet$122
  • plus $469 from 14 others

What the payments were for

  • Travel & lodging$1,74927%
  • Food & beverage$2,07732%
  • Education$2,06432%
  • Other$5168%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,406 in reported general payments places this provider in the 50th percentile of 43 foot & ankle surgery providers in Nebraska.

See all foot & ankle surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$98,677
Medicare patients
274
Services billed
1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox14$712
Cephalexin28$241
Gabapentin15$119
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$111
Tramadol Hcl13$49

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →